GANX
Gain Therapeutics, Inc. Common StockstockNASDAQ
Market OpenNov 17, 2026 12:13:58 PM EST
1.24USD+31.355%(+0.29)1,995,725
Pre-marketNov 17, 2026 9:25:30 AM EST
0.98USD+4.233%(+0.04)
GANX Financials
In Q3 FY 2026 (ended ), Gain Therapeutics, Inc. Common Stock (GANX) reported net income of −$3.16M, operating cash flow of −$3.05M, and assets of $13.23M (filed ).
Loading financial statements…